Explore how the Inflation Reduction Act aims to improve health equity in the U.S. by lowering Medicare drug costs and redesigning benefits. Learn why real-world data is crucial for measuring the law's impact on patient outcomes, access, and disparities, and how life sciences companies can leverage these insights to drive more equitable healthcare.